nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ABCB1—lung cancer	0.233	1	CbGaD
Metoprolol—SLC22A2—Vinblastine—lung cancer	0.0538	0.106	CbGbCtD
Metoprolol—SLC22A2—Cisplatin—lung cancer	0.0493	0.097	CbGbCtD
Metoprolol—CYP2C19—Gefitinib—lung cancer	0.0374	0.0735	CbGbCtD
Metoprolol—CYP2C19—Teniposide—lung cancer	0.0362	0.0713	CbGbCtD
Metoprolol—ABCB1—Topotecan—lung cancer	0.033	0.0649	CbGbCtD
Metoprolol—ABCB1—Gefitinib—lung cancer	0.0301	0.0593	CbGbCtD
Metoprolol—CYP2D6—Gefitinib—lung cancer	0.0284	0.0559	CbGbCtD
Metoprolol—ABCB1—Vinorelbine—lung cancer	0.0232	0.0457	CbGbCtD
Metoprolol—CYP2D6—Vinorelbine—lung cancer	0.0219	0.0431	CbGbCtD
Metoprolol—ABCB1—Crizotinib—lung cancer	0.0185	0.0364	CbGbCtD
Metoprolol—ABCB1—Gemcitabine—lung cancer	0.0181	0.0355	CbGbCtD
Metoprolol—ABCB1—Erlotinib—lung cancer	0.0178	0.0351	CbGbCtD
Metoprolol—CYP2D6—Erlotinib—lung cancer	0.0168	0.0331	CbGbCtD
Metoprolol—ABCB1—Paclitaxel—lung cancer	0.0163	0.0321	CbGbCtD
Metoprolol—ABCB1—Irinotecan—lung cancer	0.0161	0.0317	CbGbCtD
Metoprolol—ABCB1—Vinblastine—lung cancer	0.0143	0.0282	CbGbCtD
Metoprolol—CYP2D6—Vinblastine—lung cancer	0.0135	0.0265	CbGbCtD
Metoprolol—ABCB1—Cisplatin—lung cancer	0.0131	0.0258	CbGbCtD
Metoprolol—ABCB1—Etoposide—lung cancer	0.0129	0.0254	CbGbCtD
Metoprolol—ABCB1—Docetaxel—lung cancer	0.0118	0.0232	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—lung cancer	0.00879	0.0173	CbGbCtD
Metoprolol—ABCB1—Methotrexate—lung cancer	0.00852	0.0168	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—lung cancer	0.00828	0.0163	CbGbCtD
Metoprolol—Chlorphenesin—PTGS2—lung cancer	0.000204	0.278	CrCbGaD
Metoprolol—Atenolol—ABCB1—lung cancer	0.000174	0.236	CrCbGaD
Metoprolol—Acebutolol—ABCB1—lung cancer	0.00016	0.218	CrCbGaD
Metoprolol—Propranolol—CYP1A1—lung cancer	0.000129	0.175	CrCbGaD
Metoprolol—Depression—Methotrexate—lung cancer	0.000115	0.000603	CcSEcCtD
Metoprolol—Hypotension—Etoposide—lung cancer	0.000115	0.000602	CcSEcCtD
Metoprolol—Pain—Cisplatin—lung cancer	0.000114	0.000601	CcSEcCtD
Metoprolol—Vomiting—Vinorelbine—lung cancer	0.000114	0.000597	CcSEcCtD
Metoprolol—Body temperature increased—Gemcitabine—lung cancer	0.000114	0.000596	CcSEcCtD
Metoprolol—Rash—Vinorelbine—lung cancer	0.000113	0.000592	CcSEcCtD
Metoprolol—Dermatitis—Vinorelbine—lung cancer	0.000113	0.000591	CcSEcCtD
Metoprolol—Hypotension—Paclitaxel—lung cancer	0.000112	0.00059	CcSEcCtD
Metoprolol—Headache—Vinorelbine—lung cancer	0.000112	0.000588	CcSEcCtD
Metoprolol—Syncope—Docetaxel—lung cancer	0.000112	0.000588	CcSEcCtD
Metoprolol—Conjunctivitis—Methotrexate—lung cancer	0.000112	0.000588	CcSEcCtD
Metoprolol—Leukopenia—Docetaxel—lung cancer	0.000112	0.000587	CcSEcCtD
Metoprolol—Sweating—Methotrexate—lung cancer	0.00011	0.00058	CcSEcCtD
Metoprolol—Palpitations—Docetaxel—lung cancer	0.00011	0.000579	CcSEcCtD
Metoprolol—Feeling abnormal—Cisplatin—lung cancer	0.00011	0.000579	CcSEcCtD
Metoprolol—Paraesthesia—Etoposide—lung cancer	0.00011	0.000578	CcSEcCtD
Metoprolol—Loss of consciousness—Docetaxel—lung cancer	0.00011	0.000576	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00011	0.000575	CcSEcCtD
Metoprolol—Dyspnoea—Etoposide—lung cancer	0.000109	0.000574	CcSEcCtD
Metoprolol—Somnolence—Etoposide—lung cancer	0.000109	0.000572	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—lung cancer	0.000109	0.000572	CcSEcCtD
Metoprolol—Hepatobiliary disease—Methotrexate—lung cancer	0.000109	0.000572	CcSEcCtD
Metoprolol—Insomnia—Paclitaxel—lung cancer	0.000109	0.000571	CcSEcCtD
Metoprolol—Hypersensitivity—Irinotecan—lung cancer	0.000109	0.00057	CcSEcCtD
Metoprolol—Paraesthesia—Paclitaxel—lung cancer	0.000108	0.000567	CcSEcCtD
Metoprolol—Hypertension—Docetaxel—lung cancer	0.000108	0.000566	CcSEcCtD
Metoprolol—Agranulocytosis—Methotrexate—lung cancer	0.000107	0.000564	CcSEcCtD
Metoprolol—Dyspnoea—Paclitaxel—lung cancer	0.000107	0.000563	CcSEcCtD
Metoprolol—Somnolence—Paclitaxel—lung cancer	0.000107	0.000561	CcSEcCtD
Metoprolol—Arthralgia—Docetaxel—lung cancer	0.000106	0.000558	CcSEcCtD
Metoprolol—Chest pain—Docetaxel—lung cancer	0.000106	0.000558	CcSEcCtD
Metoprolol—Nausea—Vinorelbine—lung cancer	0.000106	0.000557	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Etoposide—lung cancer	0.000106	0.000556	CcSEcCtD
Metoprolol—Dyspepsia—Paclitaxel—lung cancer	0.000106	0.000556	CcSEcCtD
Metoprolol—Body temperature increased—Cisplatin—lung cancer	0.000106	0.000556	CcSEcCtD
Metoprolol—Asthenia—Irinotecan—lung cancer	0.000106	0.000555	CcSEcCtD
Metoprolol—Fatigue—Etoposide—lung cancer	0.000106	0.000555	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000106	0.000554	CcSEcCtD
Metoprolol—Pain—Etoposide—lung cancer	0.000105	0.000551	CcSEcCtD
Metoprolol—Constipation—Etoposide—lung cancer	0.000105	0.000551	CcSEcCtD
Metoprolol—Dry mouth—Docetaxel—lung cancer	0.000104	0.000546	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000104	0.000545	CcSEcCtD
Metoprolol—Fatigue—Paclitaxel—lung cancer	0.000104	0.000544	CcSEcCtD
Metoprolol—Hepatitis—Methotrexate—lung cancer	0.000103	0.000543	CcSEcCtD
Metoprolol—Asthenia—Gemcitabine—lung cancer	0.000103	0.000541	CcSEcCtD
Metoprolol—Pain—Paclitaxel—lung cancer	0.000103	0.00054	CcSEcCtD
Metoprolol—Constipation—Paclitaxel—lung cancer	0.000103	0.00054	CcSEcCtD
Metoprolol—Confusional state—Docetaxel—lung cancer	0.000103	0.000539	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—lung cancer	0.000102	0.000536	CcSEcCtD
Metoprolol—Oedema—Docetaxel—lung cancer	0.000102	0.000535	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—lung cancer	0.000102	0.000534	CcSEcCtD
Metoprolol—Pruritus—Gemcitabine—lung cancer	0.000102	0.000533	CcSEcCtD
Metoprolol—Feeling abnormal—Etoposide—lung cancer	0.000101	0.000531	CcSEcCtD
Metoprolol—Diarrhoea—Irinotecan—lung cancer	0.000101	0.00053	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—lung cancer	0.0001	0.000527	CcSEcCtD
Metoprolol—Gastrointestinal pain—Etoposide—lung cancer	0.0001	0.000526	CcSEcCtD
Metoprolol—Shock—Docetaxel—lung cancer	0.0001	0.000526	CcSEcCtD
Metoprolol—Nervous system disorder—Docetaxel—lung cancer	0.0001	0.000525	CcSEcCtD
Metoprolol—Thrombocytopenia—Docetaxel—lung cancer	9.98e-05	0.000524	CcSEcCtD
Metoprolol—Visual impairment—Methotrexate—lung cancer	9.96e-05	0.000523	CcSEcCtD
Metoprolol—Tachycardia—Docetaxel—lung cancer	9.95e-05	0.000522	CcSEcCtD
Metoprolol—Feeling abnormal—Paclitaxel—lung cancer	9.91e-05	0.00052	CcSEcCtD
Metoprolol—Skin disorder—Docetaxel—lung cancer	9.9e-05	0.00052	CcSEcCtD
Metoprolol—Hypersensitivity—Cisplatin—lung cancer	9.86e-05	0.000518	CcSEcCtD
Metoprolol—Gastrointestinal pain—Paclitaxel—lung cancer	9.83e-05	0.000516	CcSEcCtD
Metoprolol—Diarrhoea—Gemcitabine—lung cancer	9.83e-05	0.000516	CcSEcCtD
Metoprolol—Dizziness—Irinotecan—lung cancer	9.75e-05	0.000512	CcSEcCtD
Metoprolol—Urticaria—Etoposide—lung cancer	9.74e-05	0.000511	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—lung cancer	9.72e-05	0.00051	CcSEcCtD
Metoprolol—Abdominal pain—Etoposide—lung cancer	9.7e-05	0.000509	CcSEcCtD
Metoprolol—Body temperature increased—Etoposide—lung cancer	9.7e-05	0.000509	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—lung cancer	9.69e-05	0.000509	CcSEcCtD
Metoprolol—Eye disorder—Methotrexate—lung cancer	9.66e-05	0.000507	CcSEcCtD
Metoprolol—Tinnitus—Methotrexate—lung cancer	9.64e-05	0.000506	CcSEcCtD
Metoprolol—Asthenia—Cisplatin—lung cancer	9.6e-05	0.000504	CcSEcCtD
Metoprolol—Cardiac disorder—Methotrexate—lung cancer	9.6e-05	0.000504	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—lung cancer	9.56e-05	0.000502	CcSEcCtD
Metoprolol—Urticaria—Paclitaxel—lung cancer	9.55e-05	0.000501	CcSEcCtD
Metoprolol—Hypotension—Docetaxel—lung cancer	9.52e-05	0.0005	CcSEcCtD
Metoprolol—Abdominal pain—Paclitaxel—lung cancer	9.51e-05	0.000499	CcSEcCtD
Metoprolol—Body temperature increased—Paclitaxel—lung cancer	9.51e-05	0.000499	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—lung cancer	9.43e-05	0.000495	CcSEcCtD
Metoprolol—Angiopathy—Methotrexate—lung cancer	9.38e-05	0.000492	CcSEcCtD
Metoprolol—Vomiting—Irinotecan—lung cancer	9.37e-05	0.000492	CcSEcCtD
Metoprolol—Immune system disorder—Methotrexate—lung cancer	9.34e-05	0.00049	CcSEcCtD
Metoprolol—Mediastinal disorder—Methotrexate—lung cancer	9.32e-05	0.000489	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—lung cancer	9.31e-05	0.000489	CcSEcCtD
Metoprolol—Rash—Irinotecan—lung cancer	9.3e-05	0.000488	CcSEcCtD
Metoprolol—Dermatitis—Irinotecan—lung cancer	9.29e-05	0.000488	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Docetaxel—lung cancer	9.29e-05	0.000487	CcSEcCtD
Metoprolol—Headache—Irinotecan—lung cancer	9.24e-05	0.000485	CcSEcCtD
Metoprolol—Insomnia—Docetaxel—lung cancer	9.22e-05	0.000484	CcSEcCtD
Metoprolol—Diarrhoea—Cisplatin—lung cancer	9.16e-05	0.000481	CcSEcCtD
Metoprolol—Paraesthesia—Docetaxel—lung cancer	9.15e-05	0.00048	CcSEcCtD
Metoprolol—Alopecia—Methotrexate—lung cancer	9.14e-05	0.00048	CcSEcCtD
Metoprolol—Vomiting—Gemcitabine—lung cancer	9.13e-05	0.000479	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—lung cancer	9.11e-05	0.000478	CcSEcCtD
Metoprolol—Dyspnoea—Docetaxel—lung cancer	9.09e-05	0.000477	CcSEcCtD
Metoprolol—Somnolence—Docetaxel—lung cancer	9.06e-05	0.000476	CcSEcCtD
Metoprolol—Mental disorder—Methotrexate—lung cancer	9.06e-05	0.000476	CcSEcCtD
Metoprolol—Rash—Gemcitabine—lung cancer	9.06e-05	0.000475	CcSEcCtD
Metoprolol—Dermatitis—Gemcitabine—lung cancer	9.05e-05	0.000475	CcSEcCtD
Metoprolol—Hypersensitivity—Etoposide—lung cancer	9.04e-05	0.000474	CcSEcCtD
Metoprolol—Headache—Gemcitabine—lung cancer	9e-05	0.000472	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—lung cancer	8.98e-05	0.000471	CcSEcCtD
Metoprolol—Dyspepsia—Docetaxel—lung cancer	8.97e-05	0.000471	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—lung cancer	8.95e-05	0.00047	CcSEcCtD
Metoprolol—Hypersensitivity—Paclitaxel—lung cancer	8.86e-05	0.000465	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—lung cancer	8.82e-05	0.000463	CcSEcCtD
Metoprolol—Dysgeusia—Methotrexate—lung cancer	8.81e-05	0.000463	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Docetaxel—lung cancer	8.8e-05	0.000462	CcSEcCtD
Metoprolol—Asthenia—Etoposide—lung cancer	8.8e-05	0.000462	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—lung cancer	8.8e-05	0.000462	CcSEcCtD
Metoprolol—Fatigue—Docetaxel—lung cancer	8.79e-05	0.000461	CcSEcCtD
Metoprolol—Nausea—Irinotecan—lung cancer	8.76e-05	0.00046	CcSEcCtD
Metoprolol—Constipation—Docetaxel—lung cancer	8.72e-05	0.000458	CcSEcCtD
Metoprolol—Pain—Docetaxel—lung cancer	8.72e-05	0.000458	CcSEcCtD
Metoprolol—Pruritus—Etoposide—lung cancer	8.68e-05	0.000455	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—lung cancer	8.63e-05	0.000453	CcSEcCtD
Metoprolol—Asthenia—Paclitaxel—lung cancer	8.63e-05	0.000453	CcSEcCtD
Metoprolol—Nausea—Gemcitabine—lung cancer	8.53e-05	0.000448	CcSEcCtD
Metoprolol—Vomiting—Cisplatin—lung cancer	8.51e-05	0.000447	CcSEcCtD
Metoprolol—Pruritus—Paclitaxel—lung cancer	8.51e-05	0.000447	CcSEcCtD
Metoprolol—Vision blurred—Methotrexate—lung cancer	8.48e-05	0.000445	CcSEcCtD
Metoprolol—Rash—Cisplatin—lung cancer	8.44e-05	0.000443	CcSEcCtD
Metoprolol—Dermatitis—Cisplatin—lung cancer	8.43e-05	0.000443	CcSEcCtD
Metoprolol—Feeling abnormal—Docetaxel—lung cancer	8.4e-05	0.000441	CcSEcCtD
Metoprolol—Diarrhoea—Etoposide—lung cancer	8.39e-05	0.00044	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—lung cancer	8.37e-05	0.000439	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—lung cancer	8.35e-05	0.000438	CcSEcCtD
Metoprolol—Gastrointestinal pain—Docetaxel—lung cancer	8.33e-05	0.000438	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—lung cancer	8.31e-05	0.000436	CcSEcCtD
Metoprolol—Diarrhoea—Paclitaxel—lung cancer	8.23e-05	0.000432	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—lung cancer	8.12e-05	0.000426	CcSEcCtD
Metoprolol—Dizziness—Etoposide—lung cancer	8.11e-05	0.000426	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—lung cancer	8.09e-05	0.000425	CcSEcCtD
Metoprolol—Vertigo—Methotrexate—lung cancer	8.09e-05	0.000425	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—lung cancer	8.07e-05	0.000424	CcSEcCtD
Metoprolol—Abdominal pain—Docetaxel—lung cancer	8.06e-05	0.000423	CcSEcCtD
Metoprolol—Body temperature increased—Docetaxel—lung cancer	8.06e-05	0.000423	CcSEcCtD
Metoprolol—Leukopenia—Methotrexate—lung cancer	8.06e-05	0.000423	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—lung cancer	8e-05	0.00042	CcSEcCtD
Metoprolol—Dizziness—Paclitaxel—lung cancer	7.95e-05	0.000417	CcSEcCtD
Metoprolol—Nausea—Cisplatin—lung cancer	7.95e-05	0.000417	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—lung cancer	7.91e-05	0.000415	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—lung cancer	7.84e-05	0.000412	CcSEcCtD
Metoprolol—Vomiting—Etoposide—lung cancer	7.8e-05	0.000409	CcSEcCtD
Metoprolol—Rash—Etoposide—lung cancer	7.73e-05	0.000406	CcSEcCtD
Metoprolol—Dermatitis—Etoposide—lung cancer	7.73e-05	0.000406	CcSEcCtD
Metoprolol—Headache—Etoposide—lung cancer	7.68e-05	0.000403	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—lung cancer	7.68e-05	0.000403	CcSEcCtD
Metoprolol—Arthralgia—Methotrexate—lung cancer	7.66e-05	0.000402	CcSEcCtD
Metoprolol—Chest pain—Methotrexate—lung cancer	7.66e-05	0.000402	CcSEcCtD
Metoprolol—Tension—Doxorubicin—lung cancer	7.65e-05	0.000401	CcSEcCtD
Metoprolol—Vomiting—Paclitaxel—lung cancer	7.65e-05	0.000401	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—lung cancer	7.63e-05	0.000401	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.61e-05	0.000399	CcSEcCtD
Metoprolol—Rash—Paclitaxel—lung cancer	7.58e-05	0.000398	CcSEcCtD
Metoprolol—Dermatitis—Paclitaxel—lung cancer	7.57e-05	0.000398	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—lung cancer	7.57e-05	0.000397	CcSEcCtD
Metoprolol—Headache—Paclitaxel—lung cancer	7.53e-05	0.000395	CcSEcCtD
Metoprolol—Hypersensitivity—Docetaxel—lung cancer	7.51e-05	0.000394	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—lung cancer	7.49e-05	0.000393	CcSEcCtD
Metoprolol—Confusional state—Methotrexate—lung cancer	7.41e-05	0.000389	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—lung cancer	7.35e-05	0.000386	CcSEcCtD
Metoprolol—Asthenia—Docetaxel—lung cancer	7.31e-05	0.000384	CcSEcCtD
Metoprolol—Nausea—Etoposide—lung cancer	7.28e-05	0.000382	CcSEcCtD
Metoprolol—Pruritus—Docetaxel—lung cancer	7.21e-05	0.000379	CcSEcCtD
Metoprolol—Nervous system disorder—Methotrexate—lung cancer	7.2e-05	0.000378	CcSEcCtD
Metoprolol—Thrombocytopenia—Methotrexate—lung cancer	7.19e-05	0.000378	CcSEcCtD
Metoprolol—Nausea—Paclitaxel—lung cancer	7.14e-05	0.000375	CcSEcCtD
Metoprolol—Skin disorder—Methotrexate—lung cancer	7.14e-05	0.000375	CcSEcCtD
Metoprolol—Hyperhidrosis—Methotrexate—lung cancer	7.1e-05	0.000373	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—lung cancer	7e-05	0.000368	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—lung cancer	6.99e-05	0.000367	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—lung cancer	6.98e-05	0.000366	CcSEcCtD
Metoprolol—Diarrhoea—Docetaxel—lung cancer	6.97e-05	0.000366	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—lung cancer	6.89e-05	0.000362	CcSEcCtD
Metoprolol—Hypotension—Methotrexate—lung cancer	6.86e-05	0.00036	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—lung cancer	6.85e-05	0.00036	CcSEcCtD
Metoprolol—Propranolol—ABCB1—lung cancer	6.83e-05	0.0929	CrCbGaD
Metoprolol—Dizziness—Docetaxel—lung cancer	6.74e-05	0.000354	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—lung cancer	6.73e-05	0.000353	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Methotrexate—lung cancer	6.69e-05	0.000351	CcSEcCtD
Metoprolol—Insomnia—Methotrexate—lung cancer	6.64e-05	0.000349	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—lung cancer	6.64e-05	0.000348	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—lung cancer	6.64e-05	0.000348	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—lung cancer	6.61e-05	0.000347	CcSEcCtD
Metoprolol—Paraesthesia—Methotrexate—lung cancer	6.6e-05	0.000346	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.59e-05	0.000346	CcSEcCtD
Metoprolol—Dyspnoea—Methotrexate—lung cancer	6.55e-05	0.000344	CcSEcCtD
Metoprolol—Somnolence—Methotrexate—lung cancer	6.53e-05	0.000343	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—lung cancer	6.49e-05	0.000341	CcSEcCtD
Metoprolol—Vomiting—Docetaxel—lung cancer	6.48e-05	0.00034	CcSEcCtD
Metoprolol—Dyspepsia—Methotrexate—lung cancer	6.47e-05	0.000339	CcSEcCtD
Metoprolol—Rash—Docetaxel—lung cancer	6.43e-05	0.000337	CcSEcCtD
Metoprolol—Dermatitis—Docetaxel—lung cancer	6.42e-05	0.000337	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—lung cancer	6.41e-05	0.000337	CcSEcCtD
Metoprolol—Headache—Docetaxel—lung cancer	6.39e-05	0.000335	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—lung cancer	6.36e-05	0.000334	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Methotrexate—lung cancer	6.34e-05	0.000333	CcSEcCtD
Metoprolol—Fatigue—Methotrexate—lung cancer	6.33e-05	0.000332	CcSEcCtD
Metoprolol—Pain—Methotrexate—lung cancer	6.28e-05	0.00033	CcSEcCtD
Metoprolol—Shock—Doxorubicin—lung cancer	6.26e-05	0.000329	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—lung cancer	6.24e-05	0.000327	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—lung cancer	6.23e-05	0.000327	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—lung cancer	6.21e-05	0.000326	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—lung cancer	6.18e-05	0.000324	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—lung cancer	6.15e-05	0.000323	CcSEcCtD
Metoprolol—Nausea—Docetaxel—lung cancer	6.05e-05	0.000318	CcSEcCtD
Metoprolol—Feeling abnormal—Methotrexate—lung cancer	6.05e-05	0.000318	CcSEcCtD
Metoprolol—Gastrointestinal pain—Methotrexate—lung cancer	6.01e-05	0.000315	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—lung cancer	5.94e-05	0.000312	CcSEcCtD
Metoprolol—Urticaria—Methotrexate—lung cancer	5.84e-05	0.000306	CcSEcCtD
Metoprolol—Body temperature increased—Methotrexate—lung cancer	5.81e-05	0.000305	CcSEcCtD
Metoprolol—Abdominal pain—Methotrexate—lung cancer	5.81e-05	0.000305	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.8e-05	0.000304	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—lung cancer	5.75e-05	0.000302	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—lung cancer	5.71e-05	0.0003	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—lung cancer	5.67e-05	0.000298	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—lung cancer	5.65e-05	0.000297	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—lung cancer	5.6e-05	0.000294	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—lung cancer	5.49e-05	0.000288	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—lung cancer	5.48e-05	0.000288	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—lung cancer	5.44e-05	0.000286	CcSEcCtD
Metoprolol—Pain—Doxorubicin—lung cancer	5.44e-05	0.000286	CcSEcCtD
Metoprolol—Hypersensitivity—Methotrexate—lung cancer	5.41e-05	0.000284	CcSEcCtD
Metoprolol—Asthenia—Methotrexate—lung cancer	5.27e-05	0.000277	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—lung cancer	5.24e-05	0.000275	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—lung cancer	5.2e-05	0.000273	CcSEcCtD
Metoprolol—Pruritus—Methotrexate—lung cancer	5.2e-05	0.000273	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—lung cancer	5.05e-05	0.000265	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—lung cancer	5.03e-05	0.000264	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—lung cancer	5.03e-05	0.000264	CcSEcCtD
Metoprolol—Diarrhoea—Methotrexate—lung cancer	5.03e-05	0.000264	CcSEcCtD
Metoprolol—Dizziness—Methotrexate—lung cancer	4.86e-05	0.000255	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—lung cancer	4.69e-05	0.000246	CcSEcCtD
Metoprolol—Vomiting—Methotrexate—lung cancer	4.67e-05	0.000245	CcSEcCtD
Metoprolol—Rash—Methotrexate—lung cancer	4.63e-05	0.000243	CcSEcCtD
Metoprolol—Dermatitis—Methotrexate—lung cancer	4.63e-05	0.000243	CcSEcCtD
Metoprolol—Headache—Methotrexate—lung cancer	4.6e-05	0.000242	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—lung cancer	4.56e-05	0.00024	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—lung cancer	4.5e-05	0.000236	CcSEcCtD
Metoprolol—Nausea—Methotrexate—lung cancer	4.36e-05	0.000229	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—lung cancer	4.35e-05	0.000228	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—lung cancer	4.21e-05	0.000221	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—lung cancer	4.04e-05	0.000212	CcSEcCtD
Metoprolol—Rash—Doxorubicin—lung cancer	4.01e-05	0.000211	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—lung cancer	4.01e-05	0.00021	CcSEcCtD
Metoprolol—Headache—Doxorubicin—lung cancer	3.98e-05	0.000209	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—lung cancer	3.78e-05	0.000198	CcSEcCtD
Metoprolol—SLC22A2—Metabolism—CYP1A1—lung cancer	1.3e-05	0.000194	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GNG11—lung cancer	1.3e-05	0.000193	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ERCC2—lung cancer	1.29e-05	0.000192	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AVP—lung cancer	1.29e-05	0.000191	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.28e-05	0.000191	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	1.28e-05	0.00019	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NCOA3—lung cancer	1.28e-05	0.000189	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADCY1—lung cancer	1.27e-05	0.000189	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCG2—lung cancer	1.27e-05	0.000189	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AVP—lung cancer	1.26e-05	0.000187	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	1.25e-05	0.000186	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ENO2—lung cancer	1.25e-05	0.000185	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HPGDS—lung cancer	1.25e-05	0.000185	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADCY1—lung cancer	1.24e-05	0.000184	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCG2—lung cancer	1.24e-05	0.000184	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.24e-05	0.000184	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDOA—lung cancer	1.24e-05	0.000184	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	1.24e-05	0.000184	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	1.23e-05	0.000183	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.22e-05	0.000181	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ENO2—lung cancer	1.22e-05	0.000181	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HPGDS—lung cancer	1.22e-05	0.000181	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HES1—lung cancer	1.22e-05	0.00018	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	1.21e-05	0.00018	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PPP2R1B—lung cancer	1.21e-05	0.000179	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTT1—lung cancer	1.21e-05	0.000179	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	1.21e-05	0.000179	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NCOA3—lung cancer	1.2e-05	0.000178	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GCLC—lung cancer	1.19e-05	0.000177	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2A6—lung cancer	1.19e-05	0.000177	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	1.19e-05	0.000177	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.19e-05	0.000177	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HES1—lung cancer	1.19e-05	0.000176	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTT1—lung cancer	1.18e-05	0.000175	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	1.18e-05	0.000175	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCG2—lung cancer	1.17e-05	0.000173	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADCY1—lung cancer	1.17e-05	0.000173	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	1.17e-05	0.000173	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2A6—lung cancer	1.17e-05	0.000173	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GCLC—lung cancer	1.17e-05	0.000173	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	1.16e-05	0.000173	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	1.15e-05	0.000171	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HPGDS—lung cancer	1.15e-05	0.00017	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ENO2—lung cancer	1.15e-05	0.00017	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.15e-05	0.00017	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.14e-05	0.000169	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	1.14e-05	0.000169	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ENO1—lung cancer	1.13e-05	0.000168	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.13e-05	0.000167	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOA1—lung cancer	1.12e-05	0.000166	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	1.12e-05	0.000166	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.11e-05	0.000165	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTT1—lung cancer	1.11e-05	0.000165	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	1.11e-05	0.000165	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ENO1—lung cancer	1.11e-05	0.000164	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.1e-05	0.000164	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GCLC—lung cancer	1.1e-05	0.000163	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2A6—lung cancer	1.1e-05	0.000163	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	1.09e-05	0.000162	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	1.09e-05	0.000161	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL2—lung cancer	1.07e-05	0.000159	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TERT—lung cancer	1.07e-05	0.000158	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL2—lung cancer	1.05e-05	0.000155	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TERT—lung cancer	1.04e-05	0.000155	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ENO1—lung cancer	1.04e-05	0.000155	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	1.03e-05	0.000154	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.03e-05	0.000153	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CG—lung cancer	1.02e-05	0.000152	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	1.02e-05	0.000151	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2E1—lung cancer	1.02e-05	0.000151	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	1.01e-05	0.00015	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NQO1—lung cancer	1e-05	0.000149	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	9.97e-06	0.000148	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2E1—lung cancer	9.92e-06	0.000147	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.84e-06	0.000146	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOA1—lung cancer	9.83e-06	0.000146	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NQO1—lung cancer	9.81e-06	0.000146	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.75e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KDR—lung cancer	9.74e-06	0.000145	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—lung cancer	9.72e-06	0.000144	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOA1—lung cancer	9.62e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KDR—lung cancer	9.53e-06	0.000141	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CREBBP—lung cancer	9.47e-06	0.000141	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.35e-06	0.000139	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2E1—lung cancer	9.35e-06	0.000139	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NQO1—lung cancer	9.24e-06	0.000137	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—STK11—lung cancer	9.06e-06	0.000134	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CD—lung cancer	8.98e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	8.98e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APC—lung cancer	8.98e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KIT—lung cancer	8.98e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	8.98e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGF—lung cancer	8.87e-06	0.000132	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—lung cancer	8.87e-06	0.000132	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—STK11—lung cancer	8.84e-06	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	8.78e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APC—lung cancer	8.78e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KIT—lung cancer	8.78e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	8.78e-06	0.00013	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGF—lung cancer	8.68e-06	0.000129	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	8.6e-06	0.000128	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—lung cancer	8.54e-06	0.000127	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.5e-06	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BRAF—lung cancer	8.44e-06	0.000125	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	8.41e-06	0.000125	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTP1—lung cancer	8.38e-06	0.000124	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—lung cancer	8.36e-06	0.000124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6R—lung cancer	8.34e-06	0.000124	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—STK11—lung cancer	8.33e-06	0.000124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	8.32e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BRAF—lung cancer	8.25e-06	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTP1—lung cancer	8.18e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	8.18e-06	0.000121	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAT—lung cancer	8.15e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6R—lung cancer	8.15e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	8.14e-06	0.000121	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.11e-06	0.00012	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	8e-06	0.000119	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAT—lung cancer	7.96e-06	0.000118	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	7.94e-06	0.000118	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCB1—lung cancer	7.93e-06	0.000118	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	7.89e-06	0.000117	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CB—lung cancer	7.83e-06	0.000116	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	7.82e-06	0.000116	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TYMS—lung cancer	7.79e-06	0.000116	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	7.77e-06	0.000115	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—lung cancer	7.76e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	7.73e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	7.72e-06	0.000115	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTP1—lung cancer	7.71e-06	0.000114	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—lung cancer	7.7e-06	0.000114	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	7.65e-06	0.000113	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TYMS—lung cancer	7.6e-06	0.000113	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	7.56e-06	0.000112	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—lung cancer	7.52e-06	0.000112	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAT—lung cancer	7.5e-06	0.000111	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1A1—lung cancer	7.3e-06	0.000108	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCB1—lung cancer	7.3e-06	0.000108	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ERCC2—lung cancer	7.24e-06	0.000107	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TYMS—lung cancer	7.17e-06	0.000106	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1A1—lung cancer	7.13e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	7.1e-06	0.000105	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—lung cancer	7.08e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MDM2—lung cancer	7.07e-06	0.000105	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ERCC2—lung cancer	7.07e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RAF1—lung cancer	7.05e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	6.97e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	6.94e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MDM2—lung cancer	6.92e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RAF1—lung cancer	6.89e-06	0.000102	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	6.88e-06	0.000102	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MTOR—lung cancer	6.88e-06	0.000102	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	6.82e-06	0.000101	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTEN—lung cancer	6.76e-06	0.0001	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MTOR—lung cancer	6.73e-06	9.98e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	6.73e-06	9.98e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1A1—lung cancer	6.71e-06	9.96e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ERCC2—lung cancer	6.66e-06	9.88e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	6.61e-06	9.81e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	6.57e-06	9.74e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	6.47e-06	9.59e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—EP300—lung cancer	6.45e-06	9.57e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	6.42e-06	9.53e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	6.39e-06	9.47e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—lung cancer	6.33e-06	9.39e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL2—lung cancer	6.32e-06	9.37e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6—lung cancer	6.29e-06	9.33e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOA1—lung cancer	6.26e-06	9.29e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	6.25e-06	9.27e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—lung cancer	6.19e-06	9.18e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL2—lung cancer	6.18e-06	9.17e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCND1—lung cancer	6.16e-06	9.14e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6—lung cancer	6.15e-06	9.12e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JUN—lung cancer	6.14e-06	9.12e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOA1—lung cancer	6.11e-06	9.07e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCND1—lung cancer	6.02e-06	8.94e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JUN—lung cancer	6.01e-06	8.92e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6e-06	8.9e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—lung cancer	5.98e-06	8.87e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	5.96e-06	8.84e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTEN—lung cancer	5.94e-06	8.82e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—lung cancer	5.85e-06	8.68e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	5.83e-06	8.65e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTEN—lung cancer	5.81e-06	8.63e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	5.8e-06	8.6e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOA1—lung cancer	5.76e-06	8.55e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CG—lung cancer	5.72e-06	8.48e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	5.67e-06	8.42e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EP300—lung cancer	5.67e-06	8.41e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CG—lung cancer	5.58e-06	8.28e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EP300—lung cancer	5.54e-06	8.23e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SRC—lung cancer	5.51e-06	8.18e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—lung cancer	5.44e-06	8.08e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SRC—lung cancer	5.39e-06	8e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	5.37e-06	7.97e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—STAT3—lung cancer	5.32e-06	7.89e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—lung cancer	5.31e-06	7.88e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NRAS—lung cancer	5.3e-06	7.87e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CREBBP—lung cancer	5.3e-06	7.87e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CG—lung cancer	5.26e-06	7.8e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	5.25e-06	7.79e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—STAT3—lung cancer	5.2e-06	7.72e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NRAS—lung cancer	5.19e-06	7.7e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CREBBP—lung cancer	5.17e-06	7.68e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	5.08e-06	7.54e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CD—lung cancer	5.03e-06	7.46e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—lung cancer	5.01e-06	7.43e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	4.97e-06	7.37e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—lung cancer	4.96e-06	7.36e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MYC—lung cancer	4.94e-06	7.33e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CD—lung cancer	4.91e-06	7.28e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CREBBP—lung cancer	4.88e-06	7.23e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—lung cancer	4.84e-06	7.19e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MYC—lung cancer	4.83e-06	7.17e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EGFR—lung cancer	4.83e-06	7.17e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PIK3CA—lung cancer	4.77e-06	7.08e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EGFR—lung cancer	4.73e-06	7.01e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CD—lung cancer	4.62e-06	6.86e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KRAS—lung cancer	4.56e-06	6.77e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—lung cancer	4.56e-06	6.77e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KRAS—lung cancer	4.46e-06	6.62e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CB—lung cancer	4.38e-06	6.5e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—lung cancer	4.34e-06	6.44e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CB—lung cancer	4.28e-06	6.35e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—lung cancer	4.24e-06	6.29e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	4.19e-06	6.22e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	4.1e-06	6.09e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—lung cancer	4.06e-06	6.02e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CB—lung cancer	4.03e-06	5.98e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—lung cancer	3.99e-06	5.92e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—lung cancer	3.97e-06	5.89e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—lung cancer	3.9e-06	5.78e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HRAS—lung cancer	3.88e-06	5.76e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HRAS—lung cancer	3.79e-06	5.63e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTEN—lung cancer	3.79e-06	5.62e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6—lung cancer	3.71e-06	5.51e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTEN—lung cancer	3.7e-06	5.48e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6—lung cancer	3.63e-06	5.39e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—EP300—lung cancer	3.61e-06	5.36e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—EP300—lung cancer	3.52e-06	5.23e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTEN—lung cancer	3.48e-06	5.17e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—lung cancer	3.43e-06	5.08e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—lung cancer	3.35e-06	4.97e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—EP300—lung cancer	3.32e-06	4.93e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PIK3CA—lung cancer	2.67e-06	3.96e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PIK3CA—lung cancer	2.61e-06	3.87e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PIK3CA—lung cancer	2.46e-06	3.65e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—lung cancer	2.18e-06	3.24e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—lung cancer	2.13e-06	3.16e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—lung cancer	2.01e-06	2.98e-05	CbGpPWpGaD
